Pfizer Director Shantanu Narayen Acquires Phantom Stock Units Under Deferred Compensation Plan
PFIZER INC
Subscribe to track PFE
Premium users can add ticker alerts and receive realtime notification updates.
Filing Summary
# Insider Transaction: PFIZER INC ($PFE)
- **Insider:** NARAYEN SHANTANU (Director)
- **Transaction:** Acquisition (Award/Deferred Compensation)
- **Security:** Phantom Stock Units
- **Shares:** 1,743.983
- **Price:** $28.67
- **Total Value:** ~$50,000.00
- **Post-Transaction Holdings:** 205,648.823 units
- **Significance:** Low (Routine Director Compensation)
Comprehensive Analysis
Overview
On September 29, 2026, Pfizer Inc. ($PFE) filed a Form 4 disclosing that Board Director Shantanu Narayen acquired 1,743.983 Phantom Stock Units on September 25, 2026. The transaction was priced at $28.67 per unit, representing a total value of approximately $50,000.
Transaction Details
- Transaction Type: Acquisition coded 'A' (Grant or award under Rule 16b-3).
- Nature of Security: Phantom Stock Units representing deferred director's compensation (including dividend equivalents). Each unit corresponds to one phantom share of common stock.
- Settlement Terms: Settled in cash or common stock at the director's election following retirement from the Board of Directors.
- Direct Ownership Post-Transaction: 205,648.823 Phantom Stock Units.
Market and Trading Assessment
This filing represents standard quarterly or periodic director compensation credited in the form of phantom stock/deferred equity under Pfizer's director compensation program rather than a discretionary open-market purchase. Consequently, it carries low trading significance for market participants.
Get Real-Time Alerts
Join our community to receive instant notifications when high-significance filings are published
Important Disclaimer
This content is drawn from public SEC filings and may contain errors. It is for informational purposes only and is not investment, legal, or tax advice.
Nothing here is a recommendation to buy, sell, or hold any security. Do your own due diligence.